HLA Web Resource for SNPs, Populations, Resources, ADRs, Diseases

Select Categories

Show Entries
Search:
PMID Allele Disease Population Drug Names SNP Class Sentence
3514234 HLA (HLA) transplantation NA NA NA unclassified
the transplantation of t cell-depleted hla-haploidentical bone marrow can correct the severe combined immunodeficiency disease (scid) caused by the inherited absence of t lymphocytes.
3514234 HLA (HLA) severe combined immunodeficiency NA NA NA unclassified
the transplantation of t cell-depleted hla-haploidentical bone marrow can correct the severe combined immunodeficiency disease (scid) caused by the inherited absence of t lymphocytes.
3514234 HLA MISMATCHED (HLA-MISMATCHED) bone marrow transplantation NA NA NA unclassified
self-tolerance to host and donor following hla-mismatched bone marrow transplantation.
3516042 HLA IDENTICAL (HLA-IDENTICAL) transplantation NA NA NA unclassified
recipients of hla-mismatched, t-cell-depleted transplants had a higher rate of bacteremia (1.33 compared with 0.64 per patient, p = 0.05) and especially systemic fungal infections (0.92 compared with 0.14 per patient, p less than 0.001) than recipients of transplants from hla-identical donors without t-cell depletion; two thirds of these infections occurred during the granulocytopenic period early after transplantation.
3516042 HLA IDENTICAL (HLA-IDENTICAL) fungal infections NA NA NA unclassified
recipients of hla-mismatched, t-cell-depleted transplants had a higher rate of bacteremia (1.33 compared with 0.64 per patient, p = 0.05) and especially systemic fungal infections (0.92 compared with 0.14 per patient, p less than 0.001) than recipients of transplants from hla-identical donors without t-cell depletion; two thirds of these infections occurred during the granulocytopenic period early after transplantation.
3516042 HLA IDENTICAL (HLA-IDENTICAL) bacteremia NA NA NA unclassified
recipients of hla-mismatched, t-cell-depleted transplants had a higher rate of bacteremia (1.33 compared with 0.64 per patient, p = 0.05) and especially systemic fungal infections (0.92 compared with 0.14 per patient, p less than 0.001) than recipients of transplants from hla-identical donors without t-cell depletion; two thirds of these infections occurred during the granulocytopenic period early after transplantation.
3516042 HLA MISMATCHED (HLA-MISMATCHED) transplantation NA NA NA unclassified
recipients of hla-mismatched, t-cell-depleted transplants had a higher rate of bacteremia (1.33 compared with 0.64 per patient, p = 0.05) and especially systemic fungal infections (0.92 compared with 0.14 per patient, p less than 0.001) than recipients of transplants from hla-identical donors without t-cell depletion; two thirds of these infections occurred during the granulocytopenic period early after transplantation.
3516042 HLA MISMATCHED (HLA-MISMATCHED) fungal infections NA NA NA unclassified
recipients of hla-mismatched, t-cell-depleted transplants had a higher rate of bacteremia (1.33 compared with 0.64 per patient, p = 0.05) and especially systemic fungal infections (0.92 compared with 0.14 per patient, p less than 0.001) than recipients of transplants from hla-identical donors without t-cell depletion; two thirds of these infections occurred during the granulocytopenic period early after transplantation.
3516042 HLA MISMATCHED (HLA-MISMATCHED) bacteremia NA NA NA unclassified
recipients of hla-mismatched, t-cell-depleted transplants had a higher rate of bacteremia (1.33 compared with 0.64 per patient, p = 0.05) and especially systemic fungal infections (0.92 compared with 0.14 per patient, p less than 0.001) than recipients of transplants from hla-identical donors without t-cell depletion; two thirds of these infections occurred during the granulocytopenic period early after transplantation.
3516042 HLA MATCHED (HLA-MATCHED) bone marrow transplantation NA NA NA unclassified
the infectious complications of bone marrow transplantation were reviewed in 43 adults, 22 of whom received transplants from hla-matched donors without t-cell depletion and 21 of whom received donor marrow pretreated with the murine anti-t-cell monoclonal antibody ct-2 and complement.
CSIR logo Trisutra csir_logo

Copyright 2024